Risk Breakdown
Financial Exposure
Governance
Double Materiality
Supply Chain
Material Risks
ESG Targets & Commitments
| Topic | Target / Metric | Status |
|---|---|---|
| Human Rights in Supply Chain | HR clauses in all contracts | Commitment |
AI Risk Summary
**JB Chemicals & Pharmaceuticals: Financial Risk Summary** JB Chemicals faces its highest financial exposure through compliance risk (10.0/10 score), with estimated remediation costs of ₹6–22 crore, primarily driven by undefined EPR (Extended Producer Responsibility) applicability and incomplete emissions reporting under SEBI BRSR Core Expansion mandates. The company's critical regulatory gap centers on BRSR P6 environmental disclosure obligations; non-compliance risks include potential SEBI enforcement action and delisting for a ₹3,723 crore revenue-scale company, creating material reputational and market-access damage. While the absence of reported Scope 1 and Scope 2 emissions data raises transparency red flags rather than immediate carbon pricing exposure, the 6.5/10 EPR exposure score indicates unquantified future waste management liabilities under India's plastic and pharmaceutical waste rules—potentially requiring significant capex and operational restructuring. Immediate action on emissions quantification, EPR status clarification, and BRSR disclosure completeness is critical to de-risk compliance penalties and regulatory escalation.
Source: JB Chemicals & Pharmaceuticals Limited BRSR Filing, FY -. Derived from the company's own public disclosures. Not investment advice or a regulatory determination.